Cervical Cancer Vaccine Bags European Inventor Award To Co-creator Professor Ian Frazer

The European Inventor awards acknowledge inventions that have made major contributions towards social, technological and economic progress.

Professor Ian Frazer, University of Queensland, Co-creator of the cervical cancer vaccine, has won the 2015 European Inventor Award under the Popular Prize section, which was decided by public vote.

The awards acknowledge inventions that //have made major contributions towards social, technological and economic progress. Professor Frazer co-created the Gardasil cervical cancer vaccine with Dr Jian Zhou.

Cervical Cancer - Types, Causes, Symptoms, Diagnosis, Treatment, Complications & Prevention
Cancer cervix refers to cancerous growth in the cervix and usually occurs in the transition called squamo-columnar junction.

“It’s a great honour to win this award and to have this research acknowledged on a global stage. Events such as this highlight the exciting and innovative research coming from institutes all over the world, and show the importance of turning that research into practical solutions,” said Professor Frazer.

Professor Frazer, the founding CEO of Brisbane’s Translational Research Institute (TRI) and chair person of the TRI Foundation, is working on a vaccine for genital herpes, a virus that affects hundreds of thousands of people, threatens newborn babies and is believed to contribute to the development of HIV.

Source-Medindia

Cost Effectiveness of HPV Primary Screening Vs. Cytology Screening for Cervical Cancer in European Countries
Which form of primary screening for cervical cancer should you opt for according to cost effectiveness and your age? Find out from this report.

Early HPV Vaccination Reduces Risk for Cervical Cancer
Early administration of HPV vaccine reduces risk for cervical cancer.

Tissue Factor Pathway Inhibitor-2 may Protect Against Cervical Cancer
Tissue factor pathway inhibitor-2 may play a role in preventing the development of cervical cancer. The expression was found to be reduced in patients with cervical cancer.